Israeli scientists from the Rehovot-based company Nucleix succeeded in developing a first of its kind blood test to diagnose lung cancer long before it spreads in the body, thus increasing the chance of survival. The test examines anomalies of the bonds holding the DNA base Cytosine.

http://www.ynetnews.com/articles/0,7340,L-4942284,00.html